Letters
Statins for primary prevention
False assumptions in NICE guidance on lipid modification
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6602 (Published 26 November 2019) Cite this as: BMJ 2019;367:l6602
- Amrit Takhar, general practitioner
- Wansford and Kings Cliffe Practice, Wansford PE8 6PL, UK
- amrit.takhar{at}nhs.net
A key message from Byrne and colleagues’ article on statins for the primary prevention of cardiovascular disease is that “uncertainty remains about the benefits of their use for primary prevention.”1 This is a worrying conclusion, as implementing NICE guidance takes up an enormous amount …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.